Tetrahydro-2-furanyl-2,4(1H,3H)-pyrimidinedione derivatives as novel antibacterial compounds against Mycobacterium
Objective/Background: Mycobacterium tuberculosis thymidine monophosphate kinase (mtTMPK) is a potential enzymatic target for the treatment of tuberculosis (TB). Materials and Methods: In this study, we performed pharmacophore-based in silico screening, targeting mtTMPK with a compound library of 461...
Main Authors: | Yuji Koseki, Hironori Kanetaka, Joji Tsunosaki, Héléne Munier-Lehmann, Shunsuke Aoki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | International Journal of Mycobacteriology |
Subjects: | |
Online Access: | http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=1;spage=61;epage=69;aulast=Koseki |
Similar Items
-
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency
by: Caterina Garone, et al.
Published: (2014-06-01) -
Challenging the Biginelli scaffold to surpass the first line antitubercular drugs: Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibition activity and molecular modelling studies
by: Mai S. El-Shoukrofy, et al.
Published: (2024-12-01) -
Analogues of Pyrimidine Nucleosides as Mycobacteria Growth Inhibitors
by: Liudmila A. Alexandrova, et al.
Published: (2022-06-01) -
Thymidine Catabolism as a Metabolic Strategy for Cancer Survival
by: Sho Tabata, et al.
Published: (2017-05-01) -
Identification of Novel Dopamine D<sub>2</sub> Receptor Ligands—A Combined In Silico/In Vitro Approach
by: Lukas Zell, et al.
Published: (2022-07-01)